Grant: Collaborative Health Research Projects
University of Calgary
$75,071.00
Regenerative therapy for the intervertebral disc
EF 2009-10
Résumé
Intervertebral disc-related low back pain is one of the most significant orthopaedic disorders in industrialized society, costing the U.S. economy some $50-100 billion annually, with comparable per capita costs to the Canadian economy. Despite the economic burden of intervertebral disc (IVD) disease, few options are available to patients. Pharmacotherapies and physical therapy treat the symptoms without treating the underlying condition, while surgical intervention has a 40% failure rate and is not practical in a significant portion of patients. Therefore new therapies are required. Regenerative medicine holds considerable promise for slowing or reversing degenerative conditions by bolstering the body's own regenerative capacity. In general, regenerative medicine systems use a combination of cells, materials, and exogenous stimuli to deliver a therapeutic package to the tissue. In this proposal, we will assemble a multidisciplinary team with expertise in stem cells, biomaterials, exogenous stimuli, and surgical methods to investigate the potential of using mesenchymal stem cells to treat IVD degeneration. Rather than develop a single implantable material, we will use our multidisciplinary approach to develop the building blocks of a complete therapeutic system, including cell expansion and preparation, biomaterial development, ex vivo and in vivo models, and surgical delivery techniques in 3 parallel, interconnected Specific Aims.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
351028-2008
Name nom
Hunter, Christopher
Department département
Mechanical and Manufacturing Engineering
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2008
Award amount
75071
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
2
Nb partie
3
Application title
Regenerative therapy for the intervertebral disc
Keyword
NA
Application summary
Intervertebral disc-related low back pain is one of the most significant orthopaedic disorders in industrialized society, costing the U.S. economy some $50-100 billion annually, with comparable per capita costs to the Canadian economy. Despite the economic burden of intervertebral disc (IVD) disease, few options are available to patients. Pharmacotherapies and physical therapy treat the symptoms without treating the underlying condition, while surgical intervention has a 40% failure rate and is not practical in a significant portion of patients. Therefore new therapies are required. Regenerative medicine holds considerable promise for slowing or reversing degenerative conditions by bolstering the body's own regenerative capacity. In general, regenerative medicine systems use a combination of cells, materials, and exogenous stimuli to deliver a therapeutic package to the tissue. In this proposal, we will assemble a multidisciplinary team with expertise in stem cells, biomaterials, exogenous stimuli, and surgical methods to investigate the potential of using mesenchymal stem cells to treat IVD degeneration. Rather than develop a single implantable material, we will use our multidisciplinary approach to develop the building blocks of a complete therapeutic system, including cell expansion and preparation, biomaterial development, ex vivo and in vivo models, and surgical delivery techniques in 3 parallel, interconnected Specific Aims.